Propanidid - Wikipedia
Propanidid is an ultra short-acting phenylacetate general anesthetic. It was originally introduced by Bayer in 1963 [2] but anaphylactic reactions caused it to be withdrawn shortly afterwards.
Propanidid: Uses, Interactions, Mechanism of Action - DrugBank …
2017年6月23日 · Propanidid DrugBank Accession Number DB13234 Background. An intravenous anesthetic that has been used for rapid induction of anesthesia and for maintenance of anesthesia of short duration. (From Martindale, The Extra Pharmacopoeia, 30th ed, p918) Type Small Molecule Groups Experimental Structure
Propanidid - an overview | ScienceDirect Topics
2003年3月18日 · Propanidid. In Meyler's Side Effects of Drugs (Sixteenth Edition), 2016. General information. Propanidid was used as an intravenous anesthetic for rapid induction and for maintenance of general anesthesia of short duration.
Propanidid - an overview | ScienceDirect Topics
Propanidid (epontol, sombrevin) This drug is an ultra-short-acting, nonbarbiturate, general anesthetic that was used successfully in human medicine until it was prohibited from sale in the 1980s following anaphylactic reactions.
Propanidid | C18H27NO5 | CID 15004 - PubChem
Propanidid | C18H27NO5 | CID 15004 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.
FBA.1420, or propanidid, was developed separately to G29.505 and has some quite different properties. Propanidid is 3-methoxy-4-(N,N diethyl carbamidomethoxy) phenylacetic acid n-propy-lester and is inactivated by plasma cholinesterases whereas G29.505 is inactivated by oxidation.
PROPANIDID - ScienceDirect
1970年3月1日 · ELLIS Propanidid is a non-barbiturate induction agent, the use of which was first reported by Dundee and Clarke (1964). The most striking feature of this drug is its transient action and the rapid recovery which follows its use.
Propanidid, a non-barbiturate intravenous anaes-thetic has been used alone or together with nitrous oxide and oxygen to provide anaesthesia for dilatation and curettage (Dundee and Clarke, 1964), and for dental extractions (Goldman and Kennedy, 1964; Swerdlow, 1965).
THE ANALGESIC ACTION AND NEURONAL MECHANISM OF PROPANIDID
Study of the recruiting response on the cortex after stimulation of the centre-median nucleus indicated that propanidid transiently inhibits the thala-mocortical pathway. The neuronal mechanisms are evidence of the existence of an analgesic property of propanidid.
Propanidid - wikidoc
Propanidid is an ultra short-acting phenylacetate general anesthetic. It was originally introduced by Bayer in 1963 [1] but anaphylactic reactions caused it to be withdrawn shortly afterwards.